Convalescent plasma is a leading treatment for coronavirus disease 2019 (COVID-19), but
there is a paucity of data identifying its therapeutic efficacy. Among 126 potential …

Chinese hamster ovary (CHO) cells, predominant hosts for recombinant biotherapeutics
production, generate lactate as a major glycolysis by‐product. High lactate levels adversely …

The commercial production of monoclonal antibodies (mAbs) has revolutionized the treatment
of many diseases, including cancer, multiple sclerosis, and rheumatoid arthritis. These …

The rapidly growing market of biologics including monoclonal antibodies has stimulated the
need to improve biomanufacturing processes including mammalian host systems such as …

Constraint-based modeling has been applied to analyze metabolism of numerous organisms
via flux balance analysis and genome-scale metabolic models, including mammalian cells …

Highlights • Nucleotide sugars are precursors to the sugars involved in protein N-glycosylation.
• Different media supplements, such as N-acetylmannosamine and uridine, impact both …

Hydrolysates are used as media supplements although their role is not well characterized.
In this study, cottonseed hydrolysates, which contained peptides and galactose as …

Due to the favorable attributes of Chinese hamster ovary (CHO) cells for therapeutic proteins
and antibodies biomanufacturing, companies generate proprietary cells with desirable …

Highlights • Chemical speciation controls metal ion bioavailability in mammalian cell cultures.
• Equilibrium modeling is a good first step, for example, using the Visual MINTEQ program. …

Chinese Hamster Ovary (CHO) cells are the preferred host systems for recombinant protein
therapeutics production including monoclonal antibodies and fusion proteins. CHO cells …